Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples